Merck and Google DeepMind spinout Isomorphic Labs will use AI to design small-molecule cancer drug candidates, but the research remains untested and far from human trials.
Merck Taps Google DeepMind Spinout Isomorphic Labs to Design Cancer Drug Candidates, With No Human Testing Yet
by | Nov 19, 2026 | Uncategorized | 0 comments

Recent Comments